InviCRO LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InviCRO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11280
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental visualization with analysis capabilities; and iPACS, a full image study data management platform that allows management, distribution, analysis, and presentation of images and data associated with studies. InviCRO offers solutions in the areas of clinical imaging, radio and medicinal chemistry, nonclinical imaging, analytics, histology and tissue imaging, and data management. The company has operations with clinical facility in Connecticut, the US; and London, the UK. InviCRO is headquartered in Boston, Massachusetts, the US.

InviCRO LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InviCRO LLC, Medical Devices Deals, 2012 to YTD 2018 9
InviCRO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InviCRO LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ambry Genetics Enters into Partnership with inviCRO 11
MPI Research Enters Into Agreement With inviCRO And 3D Imaging For Drug Discovery And Development 12
Acquisition 13
Konica Minolta Acquires inviCRO 13
inviCRO Acquires Imanova 14
inviCRO Acquires Molecular NeuroImaging 15
InviCRO LLC – Key Competitors 16
InviCRO LLC – Key Employees 17
InviCRO LLC – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Aug 02, 2018: Invicro names Dr. Brian Avants as senior director of machine learning 19
Jun 20, 2018: Invicro and Ambry Genetics Appoint Dr. Kenneth Bloom as Chief Medical Officer of Advanced Pathology and Genomic Services 20
Feb 27, 2018: Invicro Hires Edward Hogan as Senior Vice President of Clinical Operations 21
Product News 22
Mar 19, 2018: Invicro Launches AmyloidIQ to Advance Clinical Imaging Trials in Alzheimer’s Disease 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
InviCRO LLC, Pharmaceuticals & Healthcare, Key Facts 2
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Deals By Therapy Area, 2012 to YTD 2018 8
InviCRO LLC, Medical Devices Deals, 2012 to YTD 2018 9
InviCRO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ambry Genetics Enters into Partnership with inviCRO 11
MPI Research Enters Into Agreement With inviCRO And 3D Imaging For Drug Discovery And Development 12
Konica Minolta Acquires inviCRO 13
inviCRO Acquires Imanova 14
inviCRO Acquires Molecular NeuroImaging 15
InviCRO LLC, Key Competitors 16
InviCRO LLC, Key Employees 17
InviCRO LLC, Other Locations 18
InviCRO LLC, Subsidiaries 18

List of Figures
InviCRO LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InviCRO LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InviCRO LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cascades Inc.:企業の戦略・SWOT・財務情報
    Cascades Inc. - Strategy, SWOT and Corporate Finance Report Summary Cascades Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hankook Tire & Technology Co Ltd (161390):企業の財務・戦略的SWOT分析
    Hankook Tire & Technology Co Ltd (161390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, a an inactivated hepatitis A vaccine; bilive, a combined inactivated hepatitis A and B vaccine; anflu, a split viron influenz …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務情報
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • KNM Group Bhd (KNM):石油・ガス:M&Aディール及び事業提携情報
    Summary KNM Group Bhd (KNM Group) is a manufacturer of custom designed process equipment's and modular systems. The company's product portfolio includes gas waste heat recovery systems, process and pressure vessels, quench coolers, scraped surface exchangers, heat transfer equipment, membrane techno …
  • Navid Zar Chimi Ind Co:企業の戦略的SWOT分析
    Navid Zar Chimi Ind Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ICON Plc (ICLR):企業の財務・戦略的SWOT分析
    ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Helijet International Inc.:企業の戦略・SWOT・財務情報
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Isetan Mitsukoshi Holdings Ltd (3099):企業の財務・戦略的SWOT分析
    Isetan Mitsukoshi Holdings Ltd (3099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • LifeScan Inc-医療機器分野:企業M&A・提携分析
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Courtagen Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equip …
  • Medline Industries Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, ph …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ibersol S.G.P.S., S.A.:企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Urban One Inc (UONEK):企業の財務・戦略的SWOT分析
    Urban One Inc (UONEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Brightside Group:企業の戦略・SWOT・財務情報
    Brightside Group - Strategy, SWOT and Corporate Finance Report Summary Brightside Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PH&T SpA-製薬・医療分野:企業M&A・提携分析
    Summary PH&T SpA (PH&T), a subsidiary of Wise SGR SpA is a pharmaceutical company that conducts research activities. The company carries out research, development and manufacturing of generic drugs for specialist therapies, medical devices and nutraceuticals. It provides difficult to formulate presc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆